Skip to content

Business & Economy

Newcastle’s QuantuMDx Group launches rapid COVID-19 and flu test

A life sciences firm has unveiled new technology it says can identify COVID-19, flu and respiratory illnesses in minutes.

Newcastle-based QuantuMDx Group says its Q-POC equipment provides “differential diagnosis” and will enable “rapid triage and effective treatment strategies, particularly in at-risk groups of patients”.

Bosses say it will help identify co-infection earlier, which will shorten treatment and patient hospital stays, with test results returned in 35 minutes.

Jonathan O’Halloran, chief executive [pictured above], said: “The recent COVID-19 pandemic highlighted the need for rapid, high-quality PCR panels to accurately diagnose infectious diseases, and so I am pleased to announce the launch of this new respiratory panel.

“With the coming winter likely to bring parallel pressure from these viruses, on-demand rapid accurate PCR testing has the potential to provide clinicians with an optimum solution for respiratory infection control.

“We are committed to making transformative, quality rapid diagnosis accessible to everyone, so that diseases can be detected and treated earlier.”